Evaluation of Comparative Surveillance Strategies of Circulating Tumor DNA, Imaging, and Carcinoembryonic Antigen Levels in Patients With Resected Colorectal Cancer-Reference-Cited by-同舟云学术

Evaluation of Comparative Surveillance Strategies of Circulating Tumor DNA, Imaging, and Carcinoembryonic Antigen Levels in Patients With Resected Colorectal Cancer

Published:2022-03-08 Issue:3 Volume:5 Page:e221093
ISSN:2574-3805
Container-title:JAMA Network Open
language:en
Short-container-title:JAMA Netw Open

Author:

Fakih Marwan¹,Sandhu Jaideep¹,Wang Chongkai¹,Kim Jae²,Chen Yi-Jen³,Lai Lily²,Melstrom Kurt²,Kaiser Andreas²

Affiliation:

1. Department of Medical Oncology and Therapeutics Research, City of Hope Comprehensive Cancer Center, Duarte, California

2. Department of Surgery, City of Hope National Medical Center, Duarte, California

3. Department of Radiation Oncology, City of Hope National Medical Center, Duarte, California

Publisher

American Medical Association (AMA)

Subject

General Medicine

Link

https://jamanetwork.com/journals/jamanetworkopen/articlepdf/2789713/fakih_2022_oi_220060_1646151735.77576.pdf

Reference23 articles.

1. Role of follow-up in management of local recurrences of colorectal cancer: a prospective, randomized study.;Pietra;Dis Colon Rectum,1998

2. Efficacy and cost of risk-adapted follow-up in patients after colorectal cancer surgery: a prospective, randomized and controlled trial.;Secco;Eur J Surg Oncol,2002

3. Postoperative surveillance in patients with colorectal cancer who have undergone curative resection: a prospective, multicenter, randomized, controlled trial.;Rodríguez-Moranta;J Clin Oncol,2006

4. Effect of 3 to 5 years of scheduled CEA and CT follow-up to detect recurrence of colorectal cancer: the FACS randomized clinical trial.;Primrose;JAMA,2014

5. Optimal surveillance protocols after curative resection in patients with stage IV colorectal cancer: a multicenter retrospective study.;Kishiki;Dis Colon Rectum,2018

Cited by 24 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A novel risk classification model integrating CEA, ctDNA, and pTN stage for stage 3 colon cancer: a post hoc analysis of the IDEA-France trial;The Oncologist;2024-07-15

2. Decoding the Dynamics of Circulating Tumor DNA in Liquid Biopsies;Cancers;2024-07-01

3. Waiting for the “liquid revolution” in the adjuvant treatment of colon cancer patients: a review of ongoing trials;Cancer Treatment Reviews;2024-05

4. Analytical validation of NeXT Personal®, an ultra-sensitive personalized circulating tumor DNA assay;Oncotarget;2024-03-14

5. Analytical Validation of NeXT Personal^®, an Ultra-sensitive Personalized Circulating Tumor DNA Assay;2024-01-17